N2OFF shareholders approve acquisition of MitoCareX drug discovery unit

Go back to N2OFF shareholders approve acquisition of MitoCareX drug discovery unit
(NASDAQ: NITO) Delayed: 1.22 --0 (-0%)
Previous Close $1.22    52 Week High
Open $1.22    52 Week Low
Day High $1.22    P/E N/A 
Day Low $1.22    EPS
Volume 537       

(NASDAQ: SPRC) Delayed: 4.95 -0.15 (2.94%)
Previous Close $5.10    52 Week High
Open $5.11    52 Week Low
Day High $5.11    P/E N/A 
Day Low $4.95    EPS
Volume 16,974